Last Updated: 31-07-2025 | Format: PDF | Report ID:20317 | Author: Raj K
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $1,450 Million |
| What is the projected market size by 2035? | $2,440 Million |
| What is the market CAGR from 2025 to 2035? | 5.3% |
| Which region dominates the market? | US (82%) |
| Which product/service type dominates the market? | Dye Exclusion Assays (28%) |
| Which application leads the market? | Drug Discovery & Development (32%) |
| Who are the major buyers? | Pharma & Biotech Companies (39%), Academic/Research Institutions (35%) |
| What are the key market growth drivers? | Growing investment in pharmaceutical R&D and drug development pipelines; Rising adoption of automated and high-content screening technologies |
| What are the major market challenges? | High cost associated with advanced and multiplexed assay platforms remains a barrier for small- and mid-size organizations; Intense competition and price wars among leading vendors could squeeze profit margins |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? | Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Danaher Corporation, Abcam plc, PerkinElmer Inc., Creative Bioarray, Promega Corporation, Agilent Technologies, Takara Bio Inc., Becton Dickinson and Company (BD), Biotium Inc., Enzo Life Sciences, BioVision Inc., Cayman Chemical Company |
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Metabolism Assays Market: by Type (Cell-based Assays, Biochemical Assays, Consumables, Instruments, Software, Others), Application (Drug Discovery & Development, Clinical Diagnostics, Toxicology, Disease Research, Biomarker Discovery, Others), Distribution Channels (Direct Sales, Distributors, Online, Retail, Institutional, Others), Technology (Fluorescence, Colorimetric, Luminescence, Spectrophotometry, Chromatography, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Stem Cell Therapy Market Market: by Type (Allogeneic, Autologous), Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other Applications), Distribution Channels (Hospitals, Clinics, Academic & Research Institutes, Contract Research Organizations, Direct Sales, Online Channels), Technology (Stem Cell Acquisition, Stem Cell Preservation, Expansion, Sub-culture, Cryopreservation, Other Technologies), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Hemato Oncology Testing Market: by Type (Assays and Kits, Services), Application (Leukemia, Lymphoma, Myeloma, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Others), Technology (PCR, NGS, IHC, FISH, Cytogenetics, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025